Clinical efficacy of Fuzheng Jiedu Xiaoyong granules in advanced colorectal cancer (spleen deficiency and stasis toxin syndrome)

Table 3 Comparisons of T-lymphocyte subsets before and after treatment between the two groups

Group	n	CD3+ (%)		P value	CD4+ (%)		P value	CD8+ (%)		P value	CD4+/CD8+		P value
		Before treatment	After treatment		Before treatment	After treatment		Before treatment	After treatment		Before treatment	After treatment
Treatment group	36	68.90 ± 11.01	76.66 ± 10.20a,b	0.003	32.47 ± 7.80	37.44 ± 7.27a,b	0.04	31.17 ± 6.9	28.38 ± 4.51a,b	0.046	1.10 ± 3.88	1.35 ± 0.34a,b	0.014
Control group	33	69.05 ± 12.85	71.94 ± 8.90	0.291	31.63 ± 6.66	33.29 ± 7.27	0.347	31.97 ± 9.75	32.35 ± 7.96	0.862	1.10 ± 0.48	1.17 ± 0.44	0.791
P value		0.956	0.045		0.62	0.02		0.659	0.012		0.99	0.032

^aP < 0.05 vs treatment group within the same group.

^bP < 0.05 vs pre-treatment within the same group.